Año 2019 / Volumen 111 / Número 11

Carta Científica

Hepatocyte transplantation

896-897

Javier A. Cienfuegos, Fernando Rotellar, Víctor Valenti,

We have read with great interest the study by Vera MC et al. on the intrasplenic transplantation of hepatocytes from donors receiving the carcinogenic drugs diethylnitrosamine (DEN) and 2-actylaminofluorene (2-AAF). The most important conclusion of the study is that there were no signs of tumor progression in the recipient liver at seven and 60 days after hepatocellular transplantation and no differences were found in the animals with healthy hepatocyte transplants.

Valoración del lector:	Valora este artículo:
	Enviar por e-mail

Nuevo comentario

Código de seguridad:

Enviando...

Comentarios